BACKGROUND: There is substantial evidence that many depressed individuals experience impaired executive functioning. Understanding the causes of executive dysfunction in depression is clinically important because cognitive impairment is a substantial contributor to functional impairment. This study investigated whether elevated levels of an inflammatory cytokine [interleukin-6 (IL-6)] and/or higher body mass index (BMI) concurrently and/or prospectively accounted for the relationship between depressive symptoms and impaired executive functioning in adolescents. METHODS: A diverse, community sample of adolescents (N = 288; mean age = 16.33; 51.4% female; 59.0% African-American) completed assessments of height and weight, IL-6, depressive symptoms, and self-report/behavioral measures of executive functioning (selective attention, switching attention) and future orientation annually over 3 years. Adolescents experiencing acute illness or medical conditions that affect inflammation were excluded from analyses. Path analysis within a structural equation modeling framework simultaneously examined the concurrent and prospective relationships between BMI, IL-6, depressive symptoms, and the measures of cognitive functioning across three timepoints. RESULTS: Across all timepoints, higher BMI was prospectively associated with higher levels of IL-6 and depressive symptoms, while higher levels of IL-6 were associated with worse performance on three behavioral and self-report measures of cognitive functioning. Higher depressive symptoms also were prospectively associated with elevated IL-6 and both higher depressive symptoms and a higher BMI predicted worse future executive functioning via increased IL-6. CONCLUSIONS: More severe depressive symptoms and increased BMI may disrupt executive functioning via elevated IL-6.
BACKGROUND: There is substantial evidence that many depressed individuals experience impaired executive functioning. Understanding the causes of executive dysfunction in depression is clinically important because cognitive impairment is a substantial contributor to functional impairment. This study investigated whether elevated levels of an inflammatory cytokine [interleukin-6 (IL-6)] and/or higher body mass index (BMI) concurrently and/or prospectively accounted for the relationship between depressive symptoms and impaired executive functioning in adolescents. METHODS: A diverse, community sample of adolescents (N = 288; mean age = 16.33; 51.4% female; 59.0% African-American) completed assessments of height and weight, IL-6, depressive symptoms, and self-report/behavioral measures of executive functioning (selective attention, switching attention) and future orientation annually over 3 years. Adolescents experiencing acute illness or medical conditions that affect inflammation were excluded from analyses. Path analysis within a structural equation modeling framework simultaneously examined the concurrent and prospective relationships between BMI, IL-6, depressive symptoms, and the measures of cognitive functioning across three timepoints. RESULTS: Across all timepoints, higher BMI was prospectively associated with higher levels of IL-6 and depressive symptoms, while higher levels of IL-6 were associated with worse performance on three behavioral and self-report measures of cognitive functioning. Higher depressive symptoms also were prospectively associated with elevated IL-6 and both higher depressive symptoms and a higher BMI predicted worse future executive functioning via increased IL-6. CONCLUSIONS: More severe depressive symptoms and increased BMI may disrupt executive functioning via elevated IL-6.
Authors: Nathan L Sparkman; Jessica B Buchanan; Jonathan R R Heyen; Jing Chen; James L Beverly; Rodney W Johnson Journal: J Neurosci Date: 2006-10-18 Impact factor: 6.167
Authors: Leonore de Wit; Floriana Luppino; Annemieke van Straten; Brenda Penninx; Frans Zitman; Pim Cuijpers Journal: Psychiatry Res Date: 2010-05-13 Impact factor: 3.222
Authors: Daniel P Moriarity; Marin M Kautz; Naoise Mac Giollabui; Joshua Klugman; Christopher L Coe; Lauren M Ellman; Lyn Y Abramson; Lauren B Alloy Journal: Clin Psychol Sci Date: 2020-05-18
Authors: Ana Belén Fernández-Serrano; Francisco José Moya-Faz; Cesar Augusto Giner Alegría; Juan Carlos Fernández Rodríguez Journal: Brain Behav Date: 2022-05-19 Impact factor: 3.405
Authors: Naoise Mac Giollabhui; Lauren B Alloy; Dominika Swistun; Christopher L Coe; Lauren M Ellman; Daniel P Moriarity; Allison C Stumper; Lyn Y Abramson Journal: J Youth Adolesc Date: 2021-01-15
Authors: Angeles Vinuesa; Carlos Pomilio; Amal Gregosa; Melisa Bentivegna; Jessica Presa; Melina Bellotto; Flavia Saravia; Juan Beauquis Journal: Front Neurosci Date: 2021-04-23 Impact factor: 4.677
Authors: Naoise Mac Giollabhui; Lauren B Alloy; Lizanne J S Schweren; Catharina A Hartman Journal: Brain Behav Immun Date: 2021-05-27 Impact factor: 19.227